APOBEC editing in HIV DNA proviral vif and pol long-reads issued from virologically-suppressed patients included in the ANRS LAMIDOL trial

European Meeting on HIV & Hepatitis 2021

A Multi-Allelic Molecular-Beacon-Based Real-Time RT-PCR Assay for the Detection of the Coronavirus SARS-CoV-2 from Clinical Samples

European Meeting on HIV & Hepatitis 2021

Use of Fibroquel® (type I polymerized collagen) in patients with hypoxemic inflammatory pneumonia secondary to COVID-19 in Veracruz, Mexico.

European Meeting on HIV & Hepatitis 2021

Longitudinal Evaluation of Sequencing Quality in EQA-Schemes from 2014 to 2020

European Meeting on HIV & Hepatitis 2021

PK-virological algorithm to target risk of resistance among key populations in Togo

European Meeting on HIV & Hepatitis 2021

Association of APOBEC3 activity in HIV-1 DNA with non-B HIV-1 and low HIV-1 reservoir

European Meeting on HIV & Hepatitis 2021

Characterization of the newly proposed HIV-1 lineage within subtype A, sub-subtype A7

European Meeting on HIV & Hepatitis 2021

Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019

European Meeting on HIV & Hepatitis 2021

Epidemiology and transmission of drug resistance mutations among treatment-naïve people living with HIV-1 in Israel, 2010-2018

European Meeting on HIV & Hepatitis 2021

Assessment of HIV-1 DNA quantification methods in the Italian HIV DNA Network

European Meeting on HIV & Hepatitis 2021

Nervous system pathology of HIV-positive people in the large industrial center within the Russian Federation: epidemiological analysis

European Meeting on HIV & Hepatitis 2021

AIDS mortality and lethality in Minsk, Belarus

European Meeting on HIV & Hepatitis 2021

Co-infections with hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern Romania

European Meeting on HIV & Hepatitis 2021

Molecular Epidemiology Analysis Reveals Actively Growing Transmission Clusters in the Polyphyletic HIV-1 Infection in Cyprus (2019-2020)

European Meeting on HIV & Hepatitis 2021

Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from Ukraine

European Meeting on HIV & Hepatitis 2021

Pharmacist-led telephone clinic is an effective strategy for treating patients with hepatitis C and removing barriers to attending appointments

European Meeting on HIV & Hepatitis 2021

A Public Health Approach to Sustainability of Community Based HCV Treatment among HIV/HCV Co-infected KPs through programmatic cost efficiency in Ukraine

European Meeting on HIV & Hepatitis 2021

How Carbon Nanotubes can orchestrate the immunological response? Perspectives in vaccine application

European Meeting on HIV & Hepatitis 2021

Frequency of IN gene region polymorphisms associated with ALLINIs effectiveness in HIV-1 subtype A6 dominating in Russia

European Meeting on HIV & Hepatitis 2021

Pretreated drug-resistance in newly diagnosed HIV-1 patients in Portugal between 2014 and 2019

European Meeting on HIV & Hepatitis 2021

Application of the genetic diversity analysis for determination of HIV infection duration

European Meeting on HIV & Hepatitis 2021

Integrase genotyping is highly effective on diverse HIV-1 non-B clades circulating in Cameroon: toward a successful transition to Dolutegravir-based regimens in Africa

European Meeting on HIV & Hepatitis 2021

Comparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurement

European Meeting on HIV & Hepatitis 2021

Sensitivity of ultra-deep sequencing for dual HIV infection detection

European Meeting on HIV & Hepatitis 2021